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LIPOAMIDE DEHYDROGENASE 
DEFICIENCY: A NEW CAUSE FOR 
RECURRENT MYOGLOBINURIA
O.N. ELPELEG, MD, A.B. SAADA, PhD, A. SHAAG, MSc, J.2. GLUSTEIN, MD, 
W. RUITENBEEK, PhD, I. TEIN, MD, and J. HALEVY, MD
Inborn errors of pyruvate metabolism and the mito­
chondrial respiratory chain are rarely associated with 
recurrent myoglobinuria. A defect in the proteins 
containing iron-sulfur clusters, including compo­
nents of the Krebs cycle and the mitochondrial re­
spiratory chain, was found in 1 patienth and dele­
tions of m ito ch o n d ria l  DNA (mtDNA) were 
reported in 3 patients .8,13 Severe coenzyme Q  defi­
ciency in muscle was detected in 2  sisters who sufferd 
since early childhood from recurrent myoglobinuria 
and myopathy, short stature, seizure disorder, and 
cerebellar symptoms. 11 We describe a 37-year-old 
man with recurrent myoglubinuria and lactic acide­
mia due to deficiency of the mitochondrial enzyme 
lipoamide dehydrogenase (LAD).
CASE REPORT
A 37-year-old man of Ashkenazi-Jewish origin devel­
oped generalized weakness, recurrent vomiting, and 
weight loss of 10 kg over a period of 2 months. His 
parents, 2 sisters, and 4 children were healthy. He 
suffered several episodes of muscle weakness associ­
ated with “ anicteric hepatitis’* in the past 17 years. 
Prior to admission, he had elevated alanine amino­
transferase (ALT) (peak value, 556 U /L ; control, 
5-50 U/L) and aspartate aminotransferase (AST)
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(231 U /L ; control, 7-56 U /L ) . O n admission, he
had symmetric generalized hyporeflexia. Electromy­
ography revealed low-voltage polyphasic m otor unit 
potentials. Creatine kinase (CK) (11277 U /L ; con­
trol, 30-150 U /L ) , AST (400 U /L ), and ALT (757
U /L ) were elevated. After administration of chlor- 
promazine (12.5 mg IV) to alleviate vomiting, he was 
found pale, tachypneic, and confused, with severe 
metabolic acidosis (blood pIT 6 .8 , pCCK, 14). Serum 
lactate was 29.7 m m o l/L  (control, 0.9-2.1 m m ol/L ), 
p-hydroxybutyrate 2.77 m m ol/L  (control, 0.05-0.2 
m m ol/L ), acetoacetate 0.28 m m ol/L  (control, 0.02- 
0.15 m m ol/L ), CK 71000 U /L , serum carnitine 167 
pm ol/L  (control, 30-60 pm ol/L ), AST 591 U /L, 
and ALT 1640 with prolongation of the pro  thro m- 
bine time. T he  b ranched-chain  am ino acids in 
plasma were 1.5-2,5 times the upper limit of the 
control range. In the urine, myoglobin was strongly 
positive and organic acid analysis revealed massive 
excretion of lactic and P-hydroxybutyric acids, low- 
normal levels o f Krebs cycle components, and no 
evidence of fatty acid oxidation defect. A biopsy of 
the quadi^iceps revealed small cytoplasmic lipid 
droplets. Total muscle carnitine was 3.3 fim ol/g  tis­
sue (control, 2.7-4.6) and nonesterifled carnitine 
was 3.1 p m o l/g  tissue (control, 2.2-4.2). The patient 
recovered with complete normalization of all bio­
chemical abnorm alities, bu t repo rted  occasional 
vomiting and mild exertional myalgia. Therapy with 
lipoic acid was recom m ended but compliance was 
poor. He was rehospitalized 5 m onths later because 
of vomiting, weakness, and elevation of lactate (24,2 
m ol/L ), am m onia (150 p m o l/L ), and CK (1129 
U /L ). An intractable metabolic acidosis developed 
and the patient expired 12 h after admission. Con­
sent for autopsy was no t given.
METHODS
In the m ito ch o n d ria l en r ich ed  frac tion  of the 
muscle, the activity of citrate synthase, reduced form 
of nicotinam ide adenine d inucleotide (NADH)-
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ferricyanide reductase, antimycin-sensitive succinate- 
- c y to c h r o m e  c o x id o  re  d u e  ta se , s u c c i n a t e -  
ub iqu inone  reductase , u b iq u ino l-cy toch rom e c 
reductase, pyruvate dehyrogenase complex (PDHc), 
and cytochrome c oxidase were determined. The ac­
tivity of carnitine palmitoyltransferase was measured 
in the 600-g supernatant of the muscle and the ac­
tivities of PDHc, pyruvate decarboxylase, LAD, and 
a-ketoglutarate dehydrogenase complex (aKGDHc) 
were determ ined in muscle homogenate and in fi-
broblasts.r,,14,lH,iy
PDHc antiserum was produced in rabbits as de­
scribed by De Marcucci et al . 1 LAD antiserum was 
produced by immunization of rabbits with 0.5 mg of 
LAD (Sigma Chemicals, St, Louis, MO) in complete 
Freund’s adjuvant, followed by three boosts in in­
complete F ru en d ’s adjuvant. Muscle mitochondrial 
fractions of the patient and controls were separated 
by sodium dodecyl sulfate/polyacrylamide gel elec­
trophoresis (SDS-PAGE), transfered to polyvinyl- 
idenelluoride (PVDF) m em brane, and incubated 
with anti-PDHc o r anti-LAD an tisera. Antigen™ 
antibody complexes were visualized using the alkali- 
ne-phosphatase conjugate substrate kit (Bio-Rad 
Laboratories, Richmond, CA).
Genomic DNA was isolated and cDNA was pro­
duced from fibroblasts of the patient and 5 controls. 
Direct sequencing of the entire coding region of the 
LAD gene and of a genomic DNA fragment up to 
nt -207 was perform ed as previously described / 1
RESULTS
The enzymatic analysis revealed normal or elevated 
activities of all mitochondrial enzymes in muscle tis­
sue with the exception of PDHc (11% of the control
LAD
LAD
m in/m g protein; control, 83 ± 7.6).
The western blot disclosed reduced amount of the 
LAD protein (25% of the control) and norm al 
amounts of pyruvate decarboxylase subunits (Ela and 
Ejp), transacetylase (E2), and the X protein (Fig. 1).
No mutations were detected in the coding region 
of the cDNA of LAD and the 5' flanking region up to
nt -207.
DISCUSSION
Recurrent myoglobinuria was reported to accom­
pany at least 17 inborn errors of metabolism. These 
include six heritable defects in glycogenolysis or gly­
colysis, six in the pathway of short-, medium-, or 
long-chain fatty acid oxidation, one in the pentose 
phosphate pathway, one in the purine nucleotide 
cycle, and three in the.respiratory chain, Krebs cycle, 
and mtDNA. Partial deficiency of carnitine palmito­
yltransferase II is the most common cause of recur­
rent rhabdomyolysis.5*’12 ,1:5,1 (,,2i)
We attribute the recurrent myoglobinuria and 
lactic acidemia to LAD deficiency in this patient. 
LAD is one of the three catalytic proteins of the
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FIGURE 1. Western blot analysis: Lanes 1 and 4: 5 MS of mitochondrial protein of the patient; lanes 2, 3, 5, and 6; 5 pg of mitochondrial 
protein of 2 controls with citrate synthase activity which is similar to that of the patient; lane 7: procine LAD. Lanes 1-3 were exposed to 
anti-PDHc antiserum (this serum does not react with LAD). Lanes 4-7 were exposed to anti-LAD antiserum.
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PHDc which converts pyruvate to acetyl-CoA and a 
component of two other a-keto acid dehydrogenase 
complexes, aKGDHc and branched-chain keto acid 
dehydrogenase complex. Thus, the lactic acidemia, 
elevation of branched-chain amino acids, and reduc­
tion of both PDHc and aKGDHc as seen in our pa­
tient can all result from a single defect in LAD.
Because abnormalities of mitochondrial enzymes 
are not commonly associated with rhabdomyolysis, 
we considered the possibility that the deficiency of 
LAD was an epiphenomenon. However, the defect 
was also present in fibroblasts which were propa­
gated in culture, excluding a transient inhibition of 
the enzyme activity.
The few patients with LAD deficiency previously 
reported had a clinical picture which was in no way 
similar to that of our patient. Their disease was char­
acterized by progressive neurological deterioration 
and lactic acidemia, and most of them died within
9
the first few years of life.9,10,14,15,17 Peripheral muscle 
involvement was not previously documented. We 
have diagnosed several children with LAD clefidi- 
cency whose presentation in infancy was of hepato­
cellular failure, sparing central nervous system and 
muscle.3,4 In some of them, sequencing of the LAD 
gene revealed an insertion mutation within the 
leader sequence. In the present patient, no mutation 
was identified in the entire coding region of the LAD 
gene or in the immediate 5'-flanking region. In view 
of the reduced quantity of the enzymatic protein in 
the muscle tissue, the disease-causing mutation may 
interfere with the translation or transcription pro- 
cess; such a mutation may reside in fragments -208 
to -583 and -646 to -864, which were shown to con­
tain positive transcriptional regulatory elements and
+-t
were not yet analyzed by us.
In summaiy, the present report widens the clinical- 
spectram of LAD deficiency to include adult-onset re­
current myoglobinuria, and indicates that LAD defi­
ciency should be included in the differential diagnosis.
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